Showing results (1811-1820 of 3,264) with videos related to

Sort By:
Pageof 327
Clinical Pharmacology and Therapeutics|June 18, 2005
A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition dataDaniël M Jonker, Leslie A Kenna, Derek Leishman, et al.
BMJ Supportive & Palliative Care|September 27, 2014
Managing end of life medications at home--accounts of bereaved family carers: a qualitative interview studySheila Payne, Mary Turner, David Seamark, et al.
American Journal of Primatology|October 22, 2016
Patterns of milk macronutrients and bioactive molecules across lactation in a western lowland gorilla (Gorilla gorilla) and a Sumatran orangutan (Pongo abelii)Michael L Power, Jay Schulkin, Heather Drought, et al.
The Biochemical Journal|December 15, 1987
Specific antibodies and the selective inhibitor ICI 118233 demonstrate that the hormonally stimulated 'dense-vesicle' and peripheral-plasma-membrane cyclic AMP phosphodiesterases display distinct tissue distributions in the ratN J Pyne, N Anderson, B E Lavan, et al.
Plos One|November 9, 2018
Ehrlichia chaffeensis TRP47 enters the nucleus via a MYND-binding domain-dependent mechanism and predominantly binds enhancers of host genes associated with signal transduction, cytoskeletal organization, and immune responseClayton E Kibler, Sarah L Milligan, Tierra R Farris, et al.
The Journal of Pediatrics|August 26, 1998
Parental smoking and risk factors for cardiovascular disease in 10- to 12-year-old childrenV Burke, M P Gracey, R A Milligan, et al.
Health & Place|February 27, 2016
Unpacking the impact of older adults' home death on family care-givers' experiences of homeChristine Milligan, Mary Turner, Susan Blake, et al.
Blood Cancer Journal|November 28, 2024
Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphomaNarendranath Epperla, Melanie Lucero, Tom Bailey, et al.
ACS Pharmacology & Translational Science|March 29, 2020
Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational ModelingAmanda J Kennedy, Flavio Ballante, Johan R Johansson, et al.
Biochemistry|September 6, 1988
Purification of heterotrimeric GTP-binding proteins from brain: identification of a novel form of GoP Goldsmith, P S Backlund, K Rossiter, et al.
Pageof 327